{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:08:00Z","timestamp":1740146880609,"version":"3.37.3"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T00:00:00Z","timestamp":1660176000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021711","name":"Bayerisches Staatsministerium f\u00fcr Wissenschaft und Kunst","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021711","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Coronarettungsschirm: Free State of Bavaria"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Currently, more than 30,200,000 COVID-19 cases have been diagnosed in Germany alone. However, data regarding prevalence of COVID-19 in children, both in Germany and internationally, are sparse. We sought to evaluate the number of infected children by measuring IgG antibodies.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Oropharyngeal swabs were collected between December 2020 and August 2021 to measure SARS-CoV-2, and capillary blood for the detection of SARS-CoV-2 antibodies (by rapid test NADAL\u00ae and filter paper test Euroimmun\u00ae ELISA); venous blood was taken for validation (Roche\u00ae ECLIA and <jats:italic>recom<\/jats:italic>Line Blot) in 365 German children aged 3\u201316 years from 30 schools and preschools. We used multiple serological tests because the filter paper test Euroimmun\u00ae ELISA performs better in terms of sensitivity and specificity than the rapid test NADAL\u00ae. The Roche\u00ae ECLIA test is used to detect SARS-CoV-2 spike protein, and the recomLine Blot test is used to rule out the possibility of infection by seasonal SARS-viruses and to test for specific SARS-CoV-2 proteins (NP, RBD and S1). In addition, one parent each (n = 336), and 4\u20135 teachers\/caregivers (n = 90) per institution were tested for IgG antibodies from capillary blood samples. The total study duration was 4 months per child, including the first follow-up after 2 months and the second after 4 months.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Of 364 children tested at baseline, 3.6% (n = 13) were positive for SARS-CoV-2 IgG antibodies using Euroimmun\u00ae ELISA. Seven children reported previously testing positive for SARS-CoV-2; each of these was confirmed by the Roche\u00ae Anti-SARS-CoV-2-ECLIA (antibody to spike protein 1) test. SARS-CoV-2 IgG antibodies persisted over a 4-month period, but levels decreased significantly (p = 0.004) within this timeframe. The median IgG values were 192.0 BAU\/ml [127.2; 288.2], 123.6 BAU\/ml [76.6; 187.7] and 89.9 BAU\/ml [57.4; 144.2] at baseline, 2 months and 4 months after baseline, respectively. During the study period, no child tested positive for SARS-CoV-2 by oropharyngeal swab. A total of 4.3% of all parents and 3.7% of teachers\/caregivers tested positive for IgG antibodies by Euroimmun\u00ae ELISA at baseline.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>We noted a rather low seroprevalence in children despite an under-reporting of SARS-CoV-2 infections. Measurement of IgG antibodies derived from capillary blood appears to be a valid tool to detect asymptomatic infections in children. However, no asymptomatic active infection was detected during the study period of 4 months in the whole cohort. Further data on SARS-CoV-2 infections in children are needed, especially in the group of &lt;5-year-olds, as there is currently no licensed vaccine for this age group in Germany. The Robert Koch Institute\u2019s Standing Commission on Vaccination (STIKO) recommended COVID-19 vaccination for 12\u201317 and 5\u201311 year olds in August 2021 and May 2022 respectively.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0272874","type":"journal-article","created":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T17:33:36Z","timestamp":1660239216000},"page":"e0272874","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Longitudinal change in SARS-CoV-2 seroprevalence in 3-to 16-year-old children: The Augsburg Plus study"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3954-2256","authenticated-orcid":true,"given":"Vincenza","family":"Leone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christa","family":"Meisinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selin","family":"Temizel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Kling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Gerstlauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael C.","family":"Fr\u00fchwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrin","family":"Burkhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2022,8,11]]},"reference":[{"key":"pone.0272874.ref001","unstructured":"Worldometers.info. Coronavirus Worldwide Graphs Dover, Delaware, U.S.A.2021 [cited 07\/22\/2022]. Available from: https:\/\/www.worldometers.info\/coronavirus\/worldwide-graphs\/."},{"journal-title":"Robert Koch-Institut (RKI), dl-de\/by-2-0","article-title":"Robert Koch-Institut (RKI): Covid-19 Dashboard","year":"2021","key":"pone.0272874.ref002"},{"issue":"5","key":"pone.0272874.ref003","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1473-3099(20)30120-1","article-title":"An interactive web-based dashboard to track COVID-19 in real time","volume":"20","author":"E Dong","year":"2020","journal-title":"The Lancet Infectious Diseases"},{"issue":"10","key":"pone.0272874.ref004","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1056\/NEJMc2001468","article-title":"Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany","volume":"382","author":"C Rothe","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"pone.0272874.ref005","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/apa.15270","article-title":"Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults","volume":"109","author":"JF Ludvigsson","year":"2020","journal-title":"Acta Paediatr"},{"issue":"9","key":"pone.0272874.ref006","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1093\/cid\/ciaa556","article-title":"SARS-CoV-2 (COVID-19): What Do We Know About Children? A Systematic Review.","volume":"71","author":"NS Mehta","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"1","key":"pone.0272874.ref007","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/20469047.2020.1781356","article-title":"Human and novel coronavirus infections in children: a review","volume":"41","author":"N Rajapakse","year":"2021","journal-title":"Paediatr Int Child Health"},{"key":"pone.0272874.ref008","first-page":"684","article-title":"Risk factors of influenza transmission in households","volume":"54","author":"C Viboud","year":"2003","journal-title":"British Journal of General Practice"},{"key":"pone.0272874.ref009","article-title":"Typically asymptomatic but with robust antibody formation: Children\u2019s unique humoral immune response to SARS-CoV-2","author":"H Renk","year":"2021","journal-title":"medRxiv"},{"key":"pone.0272874.ref010","doi-asserted-by":"crossref","first-page":"710785","DOI":"10.3389\/fped.2021.710785","article-title":"Prediction of Past SARS-CoV-2 Infections: A Prospective Cohort Study Among Swiss Schoolchildren","volume":"9","author":"J Blankenberger","year":"2021","journal-title":"Front Pediatr"},{"issue":"2","key":"pone.0272874.ref011","first-page":"149","article-title":"A Public Health Antibody Screening Indicates a 6-Fold Higher SARS-CoV-2 Exposure Rate than Reported Cases in Children","volume":"2","author":"M Hippich","year":"2021","journal-title":"Med (N Y)"},{"issue":"6","key":"pone.0272874.ref012","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/ppul.25280","article-title":"Seroprevalence of anti-SARS-CoV-2 IgG antibodies in children with household exposure to adults with COVID-19: Preliminary findings","volume":"56","author":"D Buonsenso","year":"2021","journal-title":"Pediatr Pulmonol"},{"issue":"7","key":"pone.0272874.ref013","doi-asserted-by":"crossref","first-page":"e192","DOI":"10.1093\/cid\/ciaa1702","article-title":"Prevalence of Immunoglobulin G (IgG) Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Evaluation of a Rapid MEDsan IgG Test in Children Seeking Medical Care","volume":"72","author":"KM Posfay-Barbe","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"1","key":"pone.0272874.ref014","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13052-021-01074-9","article-title":"Prevalence of SARS-CoV-2 infection in Italian pediatric population: a regional seroepidemiological study","volume":"47","author":"M Comar","year":"2021","journal-title":"Ital J Pediatr"},{"issue":"48","key":"pone.0272874.ref015","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2021.26.48.2101040","article-title":"Under-diagnosis of SARS-CoV-2 infections among children aged 0\u201315 years, a nationwide seroprevalence study, Israel, January 2020 to March 2021","volume":"26","author":"V Indenbaum","year":"2021","journal-title":"Euro Surveill"},{"key":"pone.0272874.ref016","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3389\/fped.2020.00431","article-title":"Clinical Characteristics of Children With COVID-19: A Meta-Analysis","volume":"8","author":"Y Ding","year":"2020","journal-title":"Front Pediatr"},{"key":"pone.0272874.ref017","article-title":"Weekly SARS-CoV-2 sentinel in primary schools, kindergartens and nurseries, June to November 2020, Germany","author":"M Hoch","year":"2021","journal-title":"medRxiv"},{"key":"pone.0272874.ref018","doi-asserted-by":"crossref","first-page":"633184","DOI":"10.3389\/fimmu.2021.633184","article-title":"Antibody Responses in COVID-19: A Review","volume":"12","author":"M Chvatal-Medina","year":"2021","journal-title":"Front Immunol"},{"issue":"6","key":"pone.0272874.ref019","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1016\/j.jinf.2020.09.021","article-title":"Seroprevalence of SARS-CoV-2 significantly varies with age: Preliminary results from a mass population screening","volume":"81","author":"G Pagani","year":"2020","journal-title":"J Infect"},{"issue":"5","key":"pone.0272874.ref020","first-page":"571","article-title":"A public health antibody screening indicates a marked increase of SARS-CoV-2 exposure rate in children during the second wave","volume":"2","author":"M Hippich","year":"2021","journal-title":"Med (N Y)"},{"issue":"10247","key":"pone.0272874.ref021","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0140-6736(20)31304-0","article-title":"Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study","volume":"396","author":"S Stringhini","year":"2020","journal-title":"The Lancet"},{"issue":"6","key":"pone.0272874.ref022","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1001\/jamapediatrics.2021.0001","article-title":"Prevalence of SARS-CoV-2 Infection in Children and Their Parents in Southwest Germany","volume":"175","author":"B Tonshoff","year":"2021","journal-title":"JAMA Pediatr"},{"issue":"5","key":"pone.0272874.ref023","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18052739","article-title":"SARS-CoV-2 Infection, Risk Perception, Behaviour and Preventive Measures at Schools in Berlin, Germany, during the Early Post-Lockdown Phase: A Cross-Sectional Study","volume":"18","author":"F Hommes","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"pone.0272874.ref024","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cmi.2020.10.020","article-title":"SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis","volume":"27","author":"A Rostami","year":"2021","journal-title":"Clin Microbiol Infect"},{"journal-title":"Das offizielle Hauptstadtportal: Senatskanzlei Berlin","year":"2021","author":"Corona-Lagebericht de Berlin","key":"pone.0272874.ref025"},{"key":"pone.0272874.ref026","unstructured":"Coronavirus\u2013Fallzahlen in Augsburg Stadt Augsburg: Homepage: Stadt Augsburg; 2021 [cited 2021 21.09.2021]. Available from: https:\/\/www.augsburg.de\/umwelt-soziales\/gesundheit\/coronavirus\/fallzahlen."},{"issue":"1","key":"pone.0272874.ref027","article-title":"Rapid Global Spread of the SARS-CoV-2 Delta (B.1.617.2) Variant: Spatiotemporal Variation and Public Health Impact","volume":"1","author":"Q Shi","year":"2021","journal-title":"Zoonoses"},{"issue":"3","key":"pone.0272874.ref028","doi-asserted-by":"crossref","first-page":"e1009965","DOI":"10.1371\/journal.pcbi.1009965","article-title":"Inferring age-specific differences in susceptibility to and infectiousness upon SARS-CoV-2 infection based on Belgian social contact data","volume":"18","author":"N Franco","year":"2022","journal-title":"PLoS Comput Biol"},{"key":"pone.0272874.ref029","doi-asserted-by":"crossref","first-page":"814782","DOI":"10.3389\/fcimb.2022.814782","article-title":"Unvaccinated Children Are an Important Link in the Transmission of SARS-CoV-2 Delta Variant (B1.617.2): Comparative Clinical Evidence From a Recent Community Surge","volume":"12","author":"H Li","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"pone.0272874.ref030","first-page":"1","article-title":"Increased risk of SARS-CoV-reinfection associated with emergence of Omicron in South Africa","author":"JRC Pulliam","year":"2022","journal-title":"Science"},{"issue":"28","key":"pone.0272874.ref031","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.28.2001285","article-title":"SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states, Germany, March to June 2020","volume":"25","author":"B Fischer","year":"2020","journal-title":"Euro Surveill"},{"issue":"7","key":"pone.0272874.ref032","doi-asserted-by":"crossref","first-page":"e0254516","DOI":"10.1371\/journal.pone.0254516","article-title":"Seroprevalence of antibodies against SARS-CoV-2 virus in Northern Serbia (Vojvodina): A four consecutive sentinel population-based survey study","volume":"16","author":"M Ristic","year":"2021","journal-title":"PLoS One"},{"issue":"23","key":"pone.0272874.ref033","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1001\/jama.2020.8279","article-title":"Seroprevalence of SARS-CoV-2-Specific Antibodies Among Adults in Los Angeles County, California, on April 10\u201311, 2020","volume":"323","author":"N Sood","year":"2020","journal-title":"JAMA"},{"key":"pone.0272874.ref034","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ijid.2020.10.011","article-title":"Population-based seroprevalence surveys of anti-SARS-CoV-2 antibody: An up-to-date review","volume":"101","author":"CC Lai","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"12","key":"pone.0272874.ref035","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1136\/thoraxjnl-2020-215414","article-title":"SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study","volume":"75","author":"A Shields","year":"2020","journal-title":"Thorax"},{"issue":"1 & 2","key":"pone.0272874.ref036","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4103\/ijmr.IJMR_3290_20","article-title":"Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020","volume":"152","author":"MV Murhekar","year":"2020","journal-title":"Indian J Med Res"},{"issue":"12","key":"pone.0272874.ref037","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1093\/infdis\/jiaa579","article-title":"High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, Massachusetts","volume":"222","author":"V Naranbhai","year":"2020","journal-title":"J Infect Dis"},{"key":"pone.0272874.ref038","unstructured":"Auf einen Blick: Coronavirus in Bayern [Website]. Bayerische Staatsregierung: Homepage: Bayerische Staatskanzlei (StK); 2021 [cited 2021 21.09.2021]. Available from: https:\/\/www.bayern.de\/coronavirus-in-bayern-informationen-auf-einen-blick\/."},{"key":"pone.0272874.ref039","doi-asserted-by":"crossref","first-page":"0381","DOI":"10.1371\/journal.pmed.0050074","article-title":"Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases","volume":"5","author":"J Mossong","year":"2008","journal-title":"PloS Medicine"},{"key":"pone.0272874.ref040","unstructured":"Euroimmun. Characteristics of EUROIMMUN ELISA for COVID-19 diagnostics https:\/\/www.coronavirus-diagnostics.com\/documents\/Indications\/Infections\/Coronavirus\/YI_2606_I_UK_C.pdf: EUROIMMUN; 2022. Available from: https:\/\/www.coronavirus-diagnostics.com\/documents\/Indications\/Infections\/Coronavirus\/YI_2606_I_UK_C.pdf."},{"key":"pone.0272874.ref041","doi-asserted-by":"crossref","first-page":"104468","DOI":"10.1016\/j.jcv.2020.104468","article-title":"Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies","volume":"129","author":"KG Beavis","year":"2020","journal-title":"J Clin Virol"},{"issue":"1","key":"pone.0272874.ref042","doi-asserted-by":"crossref","first-page":"7614","DOI":"10.1038\/s41598-021-87289-6","article-title":"Evaluation of 11 SARS-CoV-2 antibody tests by using samples from patients with defined IgG antibody titers","volume":"11","author":"N Lagerqvist","year":"2021","journal-title":"Sci Rep"},{"key":"pone.0272874.ref043","first-page":"1","article-title":"Diagnostic accuracy of two commercially available rapid assays for detection of IgG and IgM antibodies to SARS-CoV-2 compared to ELISA in a low-prevalence population","volume":"15","author":"K Hackner","year":"2020","journal-title":"GMS Hygiene and Infection Control"},{"issue":"8","key":"pone.0272874.ref044","doi-asserted-by":"crossref","first-page":"e0031921","DOI":"10.1128\/JCM.00319-21","article-title":"Performance of Three SARS-CoV-2 Immunoassays, Three Rapid Lateral Flow Tests, and a Novel Bead-Based Affinity Surrogate Test for the Detection of SARS-CoV-2 Antibodies in Human Serum","volume":"59","author":"M Krone","year":"2021","journal-title":"J Clin Microbiol"},{"journal-title":"Bundesministerium f\u00fcr Gesundheit","year":"2022","author":"Aktueller Impfstatus [Website]","key":"pone.0272874.ref045"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0272874","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T17:34:21Z","timestamp":1660239261000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0272874"}},"subtitle":[],"editor":[{"given":"Etsuro","family":"Ito","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,8,11]]},"references-count":45,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0272874","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2022,8,11]]}}}